© 2003 by Oxford University Press
© 2003 Oxford University Press
CORRESPONDENCE |
Recurrent Episodes of Involuntary Masticatory Spasms Induced by Continuous Infusion of Oxaliplatin
Affiliations of authors: D. Santini, B. Vincenzi, A. La Cesa, G. Tonini (Oncology), M. Casale, F. Salvinelli (Otolaryngology), Campus Bio-Medico University, Rome, Italy.
Correspondence to: Daniele Santini, MD, Campus Bio-Medico University, Via Emilio Longoni, 83, 00155 Rome, Italy (e-mail: d.santini@unicampus.it).
| The first 10% of the full text of this article appears below. |
Oxaliplatin-containing regimens are now considered standard therapeutic options for patients with metastatic colorectal cancer (1). Oxaliplatin has a very good safety profile, and the dose-limiting toxicity of oxaliplatin is neurosensory toxicity (2). In approximately 90% of patients, oxaliplatin is associated with acute reversible neurotoxicity that is characterized